The study for transfer of Nicardipine to the fetus and neonate from mothers treated with Nicardipine. -Concentrations of Nicardipine in maternal and umbilical cord blood, and breast milk
Not Applicable
Recruiting
- Conditions
- Pregnancy-induced hypertension
- Registration Number
- JPRN-UMIN000011792
- Lead Sponsor
- Saitama Medical Center Department of Obstetrics and Gynecology(Center for Maternal , Fetal and Neonatal Medicine)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Delivery before 22nd weeks of gestation (abortion). Multiple pregnancy Life threatening sever fetal anomaly and condition. Life threatening complication of the mother Patient delivered in other institution Positive screening for HBV, HCV and HIV
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Concentration measured in maternal blood,Cord blood and breast milk,
- Secondary Outcome Measures
Name Time Method